Key role for liquid biopsy in the elimination of breast cancer surgery following neoadjuvant therapy.

Grinshpun, A; Moss, J; Uziely, B

Grinshpun, A; Moss, J; Uziely, B.

Afiliación

Grinshpun A; Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel; Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, The Hebrew University-Hadassah Medical School, Jerusalem, Israel. Electronic address: albertg@hadassah.org.il.
Moss J; Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, The Hebrew University-Hadassah Medical School, Jerusalem, Israel.
Uziely B; Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

Ann Oncol ; 32(3): 423, 2021 03.

Article en En | MEDLINE | ID: mdl-33301923

Asunto(s)

Neoplasias de la Mama; Terapia Neoadyuvante; Mama; Neoplasias de la Mama/tratamiento farmacológico; Neoplasias de la Mama/cirugía; Humanos; Biopsia Líquida; Mastectomía

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Terapia Neoadyuvante Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article Pais de publicación: ENGLAND / ESCOCIA / GB / GREAT BRITAIN / INGLATERRA / REINO UNIDO / SCOTLAND / UK / UNITED KINGDOM

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google